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Cocaine use by pregnant women has been reported to cause fetal and neonatal
morbidity and mortality. We hypothesized that human neonates exposed to
cocaine via maternal use during pregnancy might manifest changes in beat-to-
beat heartratevariability, similar to those described in experimental animals. In
this preliminary report, we present findings from the first systematic analysis of
heart rate dynamics in a small group of (n = 5) neonates exposed in utero to
cocaine compared to gestationally age matched controls (n = 6) without known
drug exposure. Overall heart rate spectral power during ten minute periods of
quiescent sleep was significantly reduced (p < 0.01) in the cocaine-exposed
group, reminiscent ofthe changes recently reported in an animal model. In two
other cocaine-exposed newborns, a quiescent sleep period could not be found.
We discuss the special methodological problems associated with collection and
interpretation ofsuchdata.
Cocaine use by pregnant women has increased at an alarming rate in recent years.
Prenatal cocaine use may lead to placenta abruptio, premature delivery, intrauterine
growth retardation, congenital malformations, and fetal death [1-12]. Prenatal exposure
to cocaine is also associated with abnormalities that may be observed shortly after birth
and may persist through infancy, including: increased neonatal stress behavior, motor
development dysfunction, and central nervous system irritability with electroencephalo-
graphic abnormalities [13-17]. At present, however, we are unable to determine which
newborns have had a pathophysiologic response to prenatal cocaine exposure and which
are atrisk for long-term effects.
In view of the public health implications of this widespread problem, a readily-
employed, inexpensive, and non-invasive means of detecting and monitoring cocaine
effects on neonates would be highly desirable. Cocaine has important neuroautonomic
interactions which may be responsible for some ofits adverse long-term effects [18, 19].
Neuroautonomic control ofthe cardiovascular system is reflected in beat-to-beat fluctua-
tions in heart rate variability. Previous studies have demonstrated changes in heart rate
variability in a variety ofpathologic conditions characterized by altered neuroautonomic
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function. Such changes may be detected by traditional measures ofvariability or by new-
erapproaches based on spectral analysis and nonlinear dynamics [20-22]. Stambler et al.
[23] recently reported that cocaine administration to experimental ferrets resulted in a
marked decrease in sinus rhythm heartrate variability immediately prior to sudden death
associated with seizures or ventricular arrhythmias. Heart rate variability data in human
neonates exposed tococaine in utero, however, has been limited.
In this report, we present preliminary findings from the first systematic analysis of
heart rate dynamics in a small group of neonates exposed to cocaine compared to gesta-
tionally-aged matched controls. We also discuss the special methodological issues that
make collection and analysis of such important data sets problematic and subject to
potential misinterpretation.
METHODS
Subjects
Continuous ECGb recordings were obtained from a total of 36 newborns, 10 of
whom had been prenatally exposed to cocaine as determined by urine toxicological
screening (see below). In order to be considered for analysis ofheart rate variability, the
following initial criteria had to be met 1) ECG recording within 48 hrs of birth; 2) no
known medical problems; 3) no medication known to affect the cardiovascular system.
Subjects were included in the cocaine-exposed group only if their urine toxicological
screen was positive for cocaine or its metabolites but negative forother drugs. A total of
7 of the 10 cocaine-exposed infants met these criteria. Two of these ten infants were
excluded due to positive toxicological screens for other drugs, and one was excluded
because the ECG was recorded 20 days after birth. For an infant to be considered as a
control, there could be no medical suspicion of prenatal cocaine exposure. Therefore,
these infants did not have toxicological screens performed. Control infants were selected
with a range ofgestational ages to overlap that in the cocaine group. A total of6 control
infants were identified.
Toxicological Screens
Urine samples were ordered solely at the discretion ofthe medical staffcaring for the
infants. The present study had no influence on the determination to order a toxicological
screen oron the treatment ofeither the infants or their mothers. The major indications for
screening were a positive history ofmaternal drug use or alackofadequate prenatal care.
Even in these settings, however, permission from the parent(s) had to be obtained for a
screen tobeperformed. The samples were analyzed by standard EMIT forcocaine and its
metabolites and for other drugs including opiates, phenothiazines, amphetamines, tri-
cyclic antidepressants, ethanol, barbiturates, cannabinoids, benzodiazepines, and phency-
clidine.
DataRecording
Continuous recordings of ECG, 30-90 min in duration, were obtained from the
neonates while they slept in a bassinet. The ECG was recorded onto a digital audio tape
(TEACRD-lilT). Subsequently, the ECG signals were digitized at 500 Hz and stored on
a digital computer (MacIntosh II fx). QRS detection and beat classification were per-
formed using an automatedECG analyzer [24] with visual verification.
Data Selection
It has been well documented that sleep state greatly affects heart rate variability in
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infants [25]. Since it was not feasible to record electroencephalograms in this study, we
compared similar, quiescent sleep periods from each infant using the technique ofHarper
et al. [25]. The median heartrate and the intraquartile heart rate range (i.e., the difference
in heart rates between the values 12.5% above and below the median) were computed
over sequential 1-min segments ofdata for the entire recording period. A single continu-
ous data segment of 10 min duration, presumed to represent quiescent sleep, was chosen
for further analysis based on the following criteria: 1) the segment was withoutectopy, 2)
median heart rate and variability were lower compared to other segments, and 3) there
were no abruptchanges ineither mean heartrate orvariability.
An example of this analysis is shown in Figure 1 for one control infant and two
cocaine-exposed infants. In the control and first cocaine-exposed infant, a quiescent sleep
period is identiflable. Such a period is not clearly present, however, in the record of the
secondcocaine-exposed infant. Quiescent sleep periods could notbe identified in 2 ofthe
7 cocaine-exposed infants who satisfied the initial screening criteria described above, and
therefore theirdata were notusedforcomparison with controls.
HeartRateDynarmcs
A heart rate time series with equally-spaced samples was constructed from the
sequence of R-R intervals using linear interpolation techniques at a sampling rate of 4
Hz. Heart rate variability was quantified on the 10 min data segments by means of the
following indices. Mean heart rate and standard deviation of heart rate were calculated
for each time series. Linear trends were then removed from the time series using standard
linear regression techniques. The amplitude spectrum for each time series was computed
using aFFT- with a Hanning window. The amplitude spectrum was then smoothed with a
5 pointmoving average filter.
The power (sum of squared amplitudes) was calculated over a low frequency band
(PLF, 0.02-0.13 Hz), a medium frequency band (PMF, 0.13-0.30 Hz), and a high frequen-
cyband (PHF,0.301.1 Hz) [26]. PTwas calculated as the sum over the three bands.
ApEn, a statistic derived from dynamical systems theory, was calculated to provide a
single index of the overall "complexity" or"predictability" ofeach time series. The theo-
retical basis and computational details for ApEn have been presented by Pincus and col-
leagues [27-30]. Briefly, ApEn quantifies the regularity of the heart rate time series. The
more regular and predictable the signal, the lower its value of ApEn. This measure may
be applied to the output of deterministic ("chaotic"), stochastic, or "mixed" systems. In
this study, ApEn was calculated over N = 2400 data points. The input parameters, m and
r, were chosen to be 2 and 0.75, respectively. The value ofr was chosen as 0.20 times the
standard deviation ofthe heart rate time series averaged over all subjects as recommend-
edbyPincus et al. [27-30].
StatisticalMethods
Differences between control and cocaine-exposed infants were assessed by a two-
tailedMann-Whitney rank sum test. Level ofsignificance was defined asp <0.05.
RESULTS
Analysis ofheart rate variability was performed in 11 infants during quiescent sleep:
6 control and 5 cocaine-exposed infants. There was no difference in the mean gestational
age between the two groups (Table 1). The heart rate time series and amplitude spectra
are shown in Figure 2 for all eleven infants. The results for all infants are summarized in
Table 1.
Control and cocaine-exposed infants had similar mean heart rates. There were, how-
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Figure 1. Min by min median heart rate and variability. The median heart rate and variability
(defimed as described in the text by intraquartile range) were calculated over 1-min intervals.
Representative data are shown from a control infant (top panel) and for two cocaine-exposed
infants (lower two panels). The quiescent sleep period for which heart rate variability analysis was
performed is indicated by the segment between the arrows. Note that in the lower panel, a suitable
10 min quiescent period cannot be readily defined and, therefore, this subject was not included in
the comparison with controls.
ever, clear differences in the beat-to-beat heart rate variability between the groups.
Decreased heart rate variability in the cocaine-exposed infants was evidenced by a signif-
icant decrease in PT, resulting primarily from a reduction in PLF; PMF and PHF were also
reduced, but the changes did not achieve statistical significance. Heart rate standard devi-
ation was also lower in the cocaine group, but this difference was not statistically signifi-
cant. Ofnote, despite the wide range ofgestational ages in both groups, only one control
infant had a value of PT which overlapped the values observed in the cocaine-exposed
group. ApEn ofheart rate was also decreased in the cocaine-exposed infants, although the
difference did not reach statistical significance.
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Table 1. Heart rate dynamics.
Subject GA HRm HRsD PLF PMP PHP PT ApEn
Ni 32 134.6 4.49 6.11 0.49 0.27 6.86 0.54
N2 34 138.4 3.85 4.62 0.54 0.36 5.52 0.60
N3 33 121.1 3.45 7.87 1.32 0.75 9.94 0.82
N4 40 135.2 4.55 4.22 0.50 0.14 4.86 0.54
N5 37 125.1 4.02 4.38 0.77 3.77 8.92 1.18
N6 37 139.9 2.77 2.93 0.28 0.51 3.72 0.66
Mean 35 132.4 3.86 5.02 0.65 0.97 6.64 0.72
SD 3.0 7.6 0.67 1.73 0.36 1.39 2.41 0.25
C1 31 139.5 1.96 1.23 0.02 0.05 1.30 0.25
C2 31 138.5 1.83 1.99 0.18 0.11 2.28 0.39
C3 34 149.3 2.40 1.68 0.25 0.29 2.22 0.43
C4 39 122.2 4.31 3.14 0.81 0.77 4.72 0.86
CS 36 138.0 3.38 3.33 0.68 0.50 4.51 0.60
Mean 34 137.5 2.78 2.27 0.39 0.34 3.01 0.50
SD 3.4 9.7 1.05 0.92 0.34 0.30 0.55 0.24
p value NS NS NS (.08) 0.02 NS NS 0.02 NS
N, control infant; C, cocaine exposed infant; GA, gestational age (weeks); HRm, mean heartrate;
HRSD, standard deviation ofHR time series; PLP, spectral power in low frequency band; PAW, spec-
tral power in medium frequency band; PHF, spectral power inhighfrequency power; PT, total Spec-
tral power; ApEn, Approximate Entropy; NS, not significant.
DISCUSSION
The effects ofprenatal cocaine exposure on heartrate dynamics in the early neonatal
period have not been described before. Our preliminary findings suggest that prenatal
exposure to cocaine may alter heart rate dynamics in the early postpartum period. In par-
ticular, during quiescent sleep the cocaine-exposed infants showed a reduction primarily
in low frequency heartrate variability versus controls.
Mechanisms ofCocaineEffects onHeartRateDynamics
The alterations in heart rate variability observed in the cocaine-exposed infants
could be due to a number offactors including effects ofcocaine upon the newborn's car-
diovascular or autonomic nervous systems, mediated by direct toxicity or indirectly by
repeated reductions in uterine blood flow that occur with acute maternal cocaine admin-
istration [31]. The reduced heart rate variability observed in the 5 infants for whom a
quiescent sleep period could be identified is reminiscent of the results observed in con-
scious ferrets exposed to relatively high doses ofcocaine [23]. While there were signifi-
cant differences in the indices of heart rate variability between control and cocaine-
exposed infants, there was no difference in the mean heartrate. The lack ofeffect ofpre-
natal cocaine-exposure on mean heart rate in newborns has been reported by other inves-
tigators [32, 33]. A decrease in heart rate variability, quantified by spectral measures or
ApEn, has been observed in a number of other conditions associated with altered neu-
roautonomic control, including congestive heart failure [20], myocardial infarction [21],
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Figure 2a. Heart rate dynamics. Heart rate time series and amplitude spectra for 6 control sub-
jects.
prior to sudden cardiac death [22], sudden infantdeath syndrome [34], andaging [28].
The observed decrease in heart rate variability in the frequency band generally asso-
ciated with sympathetic nervous system activity, after exposure to a sympathomimetic
drug like cocaine, appearsparadoxical. It should be noted, however, that changes in heart
rate fluctuations in the low frequency band cannot be considered as a simple index of
directional changes in sympathetic "tone." Certain increases in sympathetic activation,
such as those associated with acute anterior wall myocardial ischemia orbaroreflex stim-
ulation during tilting [35], do correlate well with increased low frequency spectral power.
A sustained increase in sympathetic tone due toexercise, epinephrine infusion, orconges-
tive heart failure, however, actually decreases these low frequency components of heart
rate variability [36, 37]. Therefore, the spectral effects ofcocaine-exposure in the present
studyamen ot i ns twiththeknownphanogicalactions fthissympatmimetic drug.
These preliminary findings are consistent with other studies suggesting that alter-
ations in central nervous system structure and function may be substantially perturbedby
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Figure 2b. Heart rate time series and amplitude spectra for the 5 cocaine-exposed subjects during
quiescent sleep. Spectral amplitude has units of(beats permin)/sec.
prenatal cocaine exposure [17, 38]. For example, prenatal cocaine may affect elements of
the autonomic nervous system regulating respiration [38, 39, 40], temperature [38], and
sleep cycles [38]. A linkbetween prenatal cocaine exposure and sudden infant death syn-
drome has also been suggested [33, 38, 39], but this association remains controversial
[41]. The lack ofan apparent quiescent sleep period in two of the infants in this present
study might reflect an altered sleep state associated with cocaine exposure. The hypothe-
sis that cocaine exposure perturbs neuroautonomic control systems and that these effects
are reflected by changes in beat-to-beat heart rate dynamics warrants further study. From
a practical viewpoint, ECG time series analysis may provide a readily-employed method
forquantitatively monitoring theeffects ofprenatal cocaine exposure.
Limitations
This preliminary investigation highlights anumber ofimportantmethodological con-
siderations thatneed tobe addressed by future studies.82 Orioletal.: Cocaine effects onneonatalheartrate
1) Heart rate variability in normal infants is greatly affected by multiple factors,
including gestational age atbirth, postnatal age, level of arousal, and sleep stage. In this
study, we attempted to control forthese factors by confining ouranalysis to data obtained
during quiescent sleep in gestationally age-matched subjects.
2) A number of confounding factors, such as socio-economic and nutritional status
and level ofprenatal care, may bias the results ofobservational studies of this kind. No
attempt was made to account for these factors; thus, we cannot assess their influence on
thepreliminary results reported here.
4) Toxicological screening ofa neonate's urine only provides an indication ofrecent
in utero cocaine exposure, but gives no information concerning the dose, timing or
chronicity ofdrug exposure.
5) Control infants did not have a toxicological screen. Therefore, it is possible that
one or more ofthem could also have been exposed pre-natally to cocaine. This exposure,
however, should havemade thecontrol andcocaine-exposed groups similar.
ClinicalImplications andFuture Studies
Our preliminary results suggest that abuse ofcocaine by pregnant women just prior
to delivery can alter neonatal heart rate dynamics. This finding raises the possibility that
analysis of heart rate variability may help identify infants exposed in utero to cocaine, a
group atrisk for subsequent neuroautonomic and/ordevelopmental abnormalities. A large
scale study is needed to address the utility ofheart rate monitoring in identifying and fol-
lowing these potentially high risk neonates, as well as in providing information on the
effects of prenatal cocaine exposure on the development of autonomic control mecha-
nisms.
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